
CSL Limited
CMXHF | OTC
$128.50
+$6.50 (+5.33%)
Sep 22, 2026, 10:06 AM ET · Market open
TTM Period Ending | Q4 2026 Jun 29, 2026 | Q2 2026 Dec 30, 2025 | Q4 2025 Jun 29, 2025 | Q2 2025 Dec 30, 2024 | Q4 2024 Jun 29, 2024 | Q2 2024 Dec 30, 2023 | Q4 2023 Jun 29, 2023 | Q2 2023 Dec 30, 2022 | Q4 2022 Jun 29, 2022 | Q2 2022 Dec 30, 2021 | Q4 2021 Jun 29, 2021 | Q2 2021 Dec 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 15.74B | 15.69B | 15.47B | 14.96B | 15.11B | 14.3B | 13.21B | 11.58B | 10.26B | 8.97B | 7.02B | 7.46B |
Cost of Revenue | 8.22B | 8.06B | 7.83B | 7.31B | 7.45B | 7.37B | 6.82B | 5.72B | 4.81B | 4.07B | 3.03B | 3.09B |
Gross Profit | 7.52B | 7.63B | 7.64B | 7.65B | 7.66B | 6.93B | 6.39B | 5.86B | 5.45B | 4.9B | 3.99B | 4.36B |
Operating Income | 4.02B | 4.04B | 4.16B | 3.96B | 3.89B | 3.51B | 2.96B | 2.79B | 2.81B | 2.67B | 2.15B | 2.53B |
Interest Income | 30.15M | 39.06M | 37.58M | 36.09M | 40.11M | 24.12M | 38.55M | 51.14M | 16.73M | 51.51M | 105.02M | 105.14M |
Pretax Income | -4.01B | 1.61B | 3.77B | 3.54B | 3.48B | 3.17B | 2.69B | 2.61B | 2.74B | 2.82B | 2.27B | 2.39B |
Net Income | -2.53B | 1.44B | 3.04B | 2.75B | 2.72B | 2.58B | 2.26B | 2.14B | 2.22B | 2.12B | 1.64B | 1.96B |
Selling & General & Admin | 2.12B | 2.25B | 2.4B | 2.51B | 2.24B | 2.07B | 2.2B | 1.85B | 1.51B | 1.65B | 1.63B | 1.51B |
Research & Development | 1.22B | 1.35B | 1.39B | 1.42B | 1.47B | 1.35B | 1.24B | 1.23B | 1.13B | 859.68M | 676.33M | 685.68M |
Other Expenses | 145.74M | n/a | -8M | 64.25M | 72.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.49B | 3.6B | 3.78B | 3.99B | 3.89B | 3.54B | 3.44B | 3.08B | 2.64B | 2.22B | 1.84B | 1.86B |
Interest Expense | 430.58M | 432.5M | 436.49M | 670.58M | 714.72M | 499.95M | 444.19M | 299.5M | 160.85M | 131.05M | 176.48M | 116.05M |
Selling & Marketing Expenses | n/a | 872M | 1.62B | 1.58B | 1.2B | 751.2M | 734.2M | 724.96M | 680.4M | 669.18M | 661.87M | 664.85M |
Cost & Expenses | 11.71B | 11.66B | 12.09B | 11.78B | 11.22B | 10.87B | 10.24B | 8.86B | 7.6B | 7.59B | 6.18B | 5.54B |
Income Tax Expense | -1.08B | 203.52M | 591.8M | 686M | 680.92M | 573.46M | 423.23M | 463.86M | 516.09M | 477.81M | 404.82M | 435.49M |
Shares Outstanding (Basic) | 478.91M | 483.58M | 484.21M | 483.88M | 483.98M | 482.83M | 482.37M | 482.04M | 481.71M | 456.75M | 455.63M | 455.92M |
Shares Outstanding (Diluted) | 478.91M | 486.11M | 486.49M | 485.96M | 485.75M | 484.98M | 484.59M | 483.63M | 518.49M | 458.11M | 456.21M | 456.2M |
EPS (Basic) | -5.29 | 2.97 | 6.28 | 5.68 | 5.64 | 5.34 | 4.69 | 4.45 | 4.81 | 4.64 | 3.59 | 4.29 |
EPS (Diluted) | -5.29 | 2.96 | 6.25 | 5.66 | 5.62 | 5.32 | 4.68 | 4.37 | 4.73 | 4.63 | 3.59 | 4.29 |
EBITDA | 5.07B | 5.15B | 5.23B | 4.81B | 4.77B | 4.56B | 3.96B | 3.56B | 3.43B | 2.91B | 1.79B | 1.94B |
EBIT | 4.02B | 4.08B | 4.21B | 4.06B | 4.03B | 3.67B | 3.13B | 2.91B | 2.9B | 2.58B | 1.57B | 1.72B |
Depreciation & Amortization | 1.04B | 1.06B | 1.04B | 769M | 740.61M | 890.76M | 831.24M | 655.27M | 529.18M | 323.1M | 222M | 221.89M |
Add to Watchlist
Select watchlists to add or remove CMXHF